Diflunisal Completed Phase 2 Trials for Type 2 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00506298Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes